[250 Pages Report] Expanding at a high CAGR of 8.4%, the global automated cell culture systems market is projected to increase from a valuation of US$ 10.91 Billion in 2022 to US$ 20.87 Billion by 2030.
Automated cell culture systems currently account for 44.5% share in the global cell culture market. Expansion of the automated cell culture systems market is being fuelled by rising stem cell research and development, drug breakthroughs, and increased investments towards the development of innovative products.
| Attribute | Details |
|---|---|
| Automated Cell Culture Systems Market Size (2022) | US$ 10.91 Billion |
| Revenue Forecast (2030) | US$ 20.87 Billion |
| Global Market Growth Rate (2022 to 2030) | 8.4% CAGR |
| Europe Marker Share | 35.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 8.23% |
| H1, 2022 Projected | 8.44% |
| H1, 2022 Outlook | 8.24% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 20 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 01 ↑ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of automated cell culture systems is expected to incline by 01 basis point share (BPS), as per FMI analysis.
The market for automated cell culture systems observes a decline in the BPS values due to the initial costs of automation and operational management. Moreover, equipment maintenance adds to additional cost overheads, thus proposing a hindrance to the overall market growth.
Although there are additional costs to automated cell culture systems, the future outlook is expected to be positive in terms of sales within the market. This is because automated systems can assist with bulk manufacturing of cell culture with management of cross contamination, within a closed system.
The key developments in the market include the advancement of the bioprocessing industry around the globe, especially within the South Asian region.
In laboratories, automated cell culture instruments are used because they mechanically accomplish the duties needed in creating and sustaining a cell culture. These instruments are frequently employed in cytology laboratories.
Automated cell culture equipment can execute operations such as diluting samples, cultivating cultures in liquid with constant spinning, plating cultures, and placing cultures in wells. The capacity of automated cell culture systems to develop optimal cell lines across the entire range of seeding, feeding, massaging, and cell multiplication has gained in popularity.
They help achieve strict standards demands while also decreasing contamination and human mistake. In the life sciences business, automated systems are employed for a variety of cell-based screening applications for both scientific and business purposes. The automated cell culture devices market expanded at a CAGR of 6.6% from 2015 to 2021.
Demand for automated cell culture equipment is increasing as the use of high-throughput cell lines in drug discovery research grows. The automated cell culture system demand is expected to progress at a CAGR of 8.4% from 2022 to 2030, with the global market predicted to reach a valuation of US$ 20.87 Bn by 2030.
Automated cell culture facilitates the production of large numbers of high-quality cell lines for pharmacological studies, resulting in improved product safety and efficacy. Other common scientific applications include RNA interference (RNAi), cell-based drug transport, metabolism, and toxicology studies.
Principal Consultant
“Development of Novel 3D Cell Culture Techniques & Growing Need of Cell Culture Technology”
Development of novel three-dimensional cell culture techniques, as well as the increased demand for these techniques in biopharmaceutical research and vaccine production, is driving the market for automated cell culture systems.
The benefits of cell-based vaccinations are becoming more widely recognized. Researchers and manufacturers have been pushed to develop automated cell culture-based immunizations by increased global demand for novel vaccines to restrict and cure the coronavirus's transmission, as well as strict safety standards.
“Advancement in Technologies Driving Consumption of Automated Cell Culture Systems”
High-throughput screening technology has shown to be indispensable, particularly when a huge number of biological/chemical substances are being examined to treat a specific condition.
As a result, the automated cell culture systems market is expected to be driven by the use of automation and robots for speedy assessment of biochemical or biological activities.
“High Investments in R&D of Oncology Driving Europe Automated Cell Culture Systems Market Growth”
The global automated cell culture equipment market has been studied across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
North America and Europe regional markets account for more than half of the global market share for automated cell culture systems. This could be related to a rise in the use of automated cell culture vessels as a result of an increase in oncology research and drug development.
The presence of excellent laboratory facilities is also likely to help these two regions to stand out. In 2022, North America is expected to account for 25.1% and Europe is likely to hold 35.7% of the global market share.
Given the growing demand for cell-based medicine delivery, East Asia will be the most attractive market for automated cell culture products. East Asia currently is likely to account for 20.9% of the global market share.
In 2022, South Asia & Oceania together may account for 14.2% of the global market share. This is due to the technological innovations such as next-generation sequencing, increased awareness, increased healthcare expenditure in national budgets, early availability of modern technologies, and fast-developing of research activities across the region.
The Latin America & MEA automated cell culture systems markets are expected to progress at a slightly slower rate than other regions but are expected to pick up pace towards the end of the projection period. At present, Latin America & MEA are predicted to account for 2.4% & 1.5% of the global market share, respectively.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rising Cases of Cancer Driving Sales of Automated Cell Culture Systems”
Because of government assistance and strategic initiatives, the China automated cell culture systems market is expected to grow rapidly. To cater for the enormous patient population, China is putting a larger emphasis on technological advancements.
A high need for innovative therapies and solutions has arisen due to an increase in the number of elderly people as well as a high cancer incidence. Progress in the field of regenerative medicine, as well as well-developed sophisticated healthcare systems, are driving automated cell culture systems market expansion in China.
“High Spending on Healthcare Facilities Augmenting Sales Growth of Automated Cell Culture Systems”
The United States currently dominates the North America automated cell culture systems market, and this trend is likely to continue over the projection period. Growing demand for customized medications, as well as the existence of prominent companies in the market, is largely responsible for the market expansion.
Additionally, because healthcare is one of the country's top objectives, the US government is supportive of medical research. Increasing investments in the biomedical engineering industry are also boosting the country's market growth.
“Improved Technologies & Increasing Funding in R&D Boost Sales of Biotech Companies”
Over the projected period, biotech companies are expected to progress at a fast pace. The presence of a significant number of biotechnology companies, an increase in R&D investment in these firms, and a greater demand for alternative testing methods over animal techniques are all primary market drivers.
3D cell culture has advantages over 2D cell culture in terms of suitable oxygen and nutritional gradients, non-uniform cell-to-cell contacts, and realistic cell-to-cell interactions. Because of these factors, 3D cell culture is more suitable for drug discovery and advancement, leading in rising demand for automated cell culture systems.
The COVID-19 pandemic impacted a wide range of industries all across the world. Manufacturing facilities were shut down during the early stages of the pandemic. Furthermore, the financial collapse that followed the pandemic caused a significant delay in the healthcare industry's development.
Local producers and innovators, on the other hand, have a lot of opportunities in the automated cell culture systems market to develop cost-effective automated cell culture products. Demand for diagnostic and therapeutic facilities is steadily increasing, which may prompt a slew of new firms to enter the market with innovative products.
The COVID-19 pandemic is projected to tip the market in favour of automated cell culture systems, because research operations to generate efficient and effective COVID-19 vaccinations necessitate cell lines. Even once a suitable vaccine has been discovered, demand for cell lines will continue to rise as research in this field progresses.
Manufacturers of automated cell culture systems have been heavily investing in research to develop long-term solutions for both, biopharmaceutical and packaging industries. Sustainable vessel solutions are primarily made up of recyclable plastics and glass bottles.
Recycling, on the other hand, is not without its difficulties. Recycling a multi-layer flexible vessel with barrier material and base material plastic is a time-consuming task.
As a result, companies are actively investing in research aimed at making the recycling process easier. Automated cell culture systems market players are also concentrating on innovations and collaborations to enhance their market presence.
Some of the market players included in this report are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2030 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | US$ Billion for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global automated cell culture systems market is predicted to progress at a high CAGR of 8.4% from 2022 to 2030.
The global market for automated cell culture systems is currently worth US$ 10.91 Bn.
Key suppliers of automated cell culture systems are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
By the end of 2030, automated cell culture system demand is anticipated to attain a market valuation of US$ 20.87 Bn.
The Europe automated cell culture systems market currently holds 35.7% share in the global market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Service Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Global GDP Growth Outlook 4.1.2. Global Healthcare Outlook 4.1.3. Global Life Science Market Outlook 4.2. Forecast Factors - Relevance & Impact 4.2.1. Technology Development 4.2.2. End User Demand 4.2.3. Regulatory Imposition 4.2.4. Technology Shortcomings 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity 4.4. COVID19 Crisis Analysis 4.4.1. Current COVID19 Statistics and Probable Future Impact 4.4.2. Current GDP Projection and Probable Impact 4.4.3. Current Economic Projection as compared to 2008 Economic analysis 4.4.4. COVID19 and Impact Analysis 4.4.4.1. Revenue By Service 4.4.4.2. Revenue By Country 4.4.5. 2022 Market Scenario 4.4.6. Quarter by Quarter Forecast 4.4.7. Projected recovery Quarter 4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact 5. Market Context 5.1. Regulatory Scenario 5.2. Value Chain Analysis 5.3. Key Strategies Adopted By Application Service Providers 5.4. Technology Adoption Analysis 6. Global Automated Cell Culture Systems Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Opportunity Analysis, 2022-2030 7. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) By Product Type, 2015–2021 7.3. Current and Future Market Size (US$ Mn) and Forecast By Product Type, 2022-2030 7.3.1. Automated Cell Culture Storage Equipment 7.3.2. Automated Cell Culture Vessels 7.3.3. Bioreactors 7.3.4. Consumables 7.4. Market Attractiveness Analysis By Product Type 8. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Cell Culture Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Cell Culture Type, 2015–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell Culture Type, 2022-2030 8.3.1. Finite Cell Line Cultures 8.3.2. Infinite Cell Line Cultures 8.4. Market Attractiveness Analysis By Cell Culture Type 9. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2030 9.3.1. Drug Development 9.3.2. Stem Cell Research 9.3.3. Regenerative Medicine 9.3.4. Cancer Research 9.4. Market Attractiveness Analysis By Application 10. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030 10.3.1. Biotech Companies 10.3.2. Research Organizations 10.3.3. Academic Institutes 10.4. Market Attractiveness Analysis By End User 11. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by Region 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) By Region, 2015–2021 11.3. Current and Future Market Size (US$ Mn) and Forecast By Region, 2022-2030 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. East Asia 11.3.5. South Asia 11.3.6. Oceania 11.3.7. Middle East and Africa 11.4. Market Attractiveness Analysis By Region 12. North America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 12.1. Introduction 12.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 12.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 12.3.1. By Country 12.3.1.1. U.S. 12.3.1.2. Canada 12.3.2. By Product Type 12.3.3. By Cell Culture Type 12.3.4. By Application 12.3.5. By End User 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Latin America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 13.1. Introduction 13.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 13.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 13.3.1. By Country 13.3.1.1. Brazil 13.3.1.2. Mexico 13.3.1.3. Argentina 13.3.1.4. Rest of Latin America 13.3.2. By Product Type 13.3.3. By Cell Culture Type 13.3.4. By Application 13.3.5. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Europe Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 14.1. Introduction 14.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 14.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 14.3.1. By Country 14.3.1.1. Germany 14.3.1.2. Italy 14.3.1.3. France 14.3.1.4. U.K. 14.3.1.5. Spain 14.3.1.6. BENELUX 14.3.1.7. Russia 14.3.1.8. Rest of Europe 14.3.2. By Product Type 14.3.3. By Cell Culture Type 14.3.4. By Application 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. South Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 15.1. Introduction 15.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 15.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Indonesia 15.3.1.4. Malaysia 15.3.1.5. Rest of South Asia 15.3.2. By Product Type 15.3.3. By Cell Culture Type 15.3.4. By Application 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. East Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 16.1. Introduction 16.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 16.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 16.3.1. By Country 16.3.1.1. China 16.3.1.2. Japan 16.3.1.3. South Korea 16.3.2. By Product Type 16.3.3. By Cell Culture Type 16.3.4. By Application 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. Oceania Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 17.1. Introduction 17.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 17.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 17.3.1. By Country 17.3.1.1. Australia 17.3.1.2. New Zealand 17.3.2. By Product Type 17.3.3. By Cell Culture Type 17.3.4. By Application 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 18.1. Introduction 18.2. Historical Market Size (US$ Mn) By Market Taxonomy, 2015–2021 18.3. Current and Future Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022-2030 18.3.1. By Country 18.3.1.1. GCC Countries 18.3.1.2. Turkey 18.3.1.3. South Africa 18.3.1.4. Rest of Middle East and Africa 18.3.2. By Product Type 18.3.3. By Cell Culture Type 18.3.4. By Application 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Emerging & Key Countries Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 19.1. U.S. Automated Cell Culture Systems Market Analysis 19.1.1. By Product Type 19.1.2. By Cell Culture Type 19.1.3. By Application 19.1.4. By End User 19.2. Canada Automated Cell Culture Systems Market Analysis 19.2.1. By Product Type 19.2.2. By Cell Culture Type 19.2.3. By Application 19.2.4. By End User 19.3. Mexico Automated Cell Culture Systems Market Analysis 19.3.1. By Product Type 19.3.2. By Cell Culture Type 19.3.3. By Application 19.3.4. By End User 19.4. Brazil Automated Cell Culture Systems Market Analysis 19.4.1. By Product Type 19.4.2. By Cell Culture Type 19.4.3. By Application 19.4.4. By End User 19.5. U.K. Automated Cell Culture Systems Market Analysis 19.5.1. By Product Type 19.5.2. By Cell Culture Type 19.5.3. By Application 19.5.4. By End User 19.6. Germany Automated Cell Culture Systems Market Analysis 19.6.1. By Product Type 19.6.2. By Cell Culture Type 19.6.3. By Application 19.6.4. By End User 19.7. France Automated Cell Culture Systems Market Analysis 19.7.1. By Product Type 19.7.2. By Cell Culture Type 19.7.3. By Application 19.7.4. By End User 19.8. Italy Automated Cell Culture Systems Market Analysis 19.8.1. By Product Type 19.8.2. By Cell Culture Type 19.8.3. By Application 19.8.4. By End User 19.9. Spain Automated Cell Culture Systems Market Analysis 19.9.1. By Product Type 19.9.2. By Cell Culture Type 19.9.3. By Application 19.9.4. By End User 19.10. BENELUX Automated Cell Culture Systems Market Analysis 19.10.1. By Product Type 19.10.2. By Cell Culture Type 19.10.3. By Application 19.10.4. By End User 19.11. Russia Automated Cell Culture Systems Market Analysis 19.11.1. By Product Type 19.11.2. By Cell Culture Type 19.11.3. By Application 19.11.4. By End User 19.12. China Automated Cell Culture Systems Market Analysis 19.12.1. By Product Type 19.12.2. By Cell Culture Type 19.12.3. By Application 19.12.4. By End User 19.13. India Automated Cell Culture Systems Market Analysis 19.13.1. By Product Type 19.13.2. By Cell Culture Type 19.13.3. By Application 19.13.4. By End User 19.14. Japan Automated Cell Culture Systems Market Analysis 19.14.1. By Product Type 19.14.2. By Cell Culture Type 19.14.3. By Application 19.14.4. By End User 19.15. South Korea Automated Cell Culture Systems Market Analysis 19.15.1. By Product Type 19.15.2. By Cell Culture Type 19.15.3. By Application 19.15.4. By End User 19.16. ASEAN Automated Cell Culture Systems Market Analysis 19.16.1. By Product Type 19.16.2. By Cell Culture Type 19.16.3. By Application 19.16.4. By End User 19.17. Australia Automated Cell Culture Systems Market Analysis 19.17.1. By Product Type 19.17.2. By Cell Culture Type 19.17.3. By Application 19.17.4. By End User 19.18. New Zealand Automated Cell Culture Systems Market Analysis 19.18.1. By Product Type 19.18.2. By Cell Culture Type 19.18.3. By Application 19.18.4. By End User 19.19. GCC Countries Automated Cell Culture Systems Market Analysis 19.19.1. By Product Type 19.19.2. By Cell Culture Type 19.19.3. By Application 19.19.4. By End User 19.20. Turkey Automated Cell Culture Systems Market Analysis 19.20.1. By Product Type 19.20.2. By Cell Culture Type 19.20.3. By Application 19.20.4. By End User 19.21. South Africa Automated Cell Culture Systems Market Analysis 19.21.1. By Product Type 19.21.2. By Cell Culture Type 19.21.3. By Application 19.21.4. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 20.3.1. Regional Footprint by Players 20.3.2. Service Foot print by Players 20.3.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive (Tentative List) 21.3.1. Thermo Fisher Scientific 21.3.1.1. Overview 21.3.1.2. Service Portfolio 21.3.1.3. Profitability by Market Segments(Service/Channel/Country) 21.3.1.4. Service Footprint 21.3.1.5. Strategy Overview 21.3.1.5.1. Marketing Strategy 21.3.1.5.2. Service Strategy 21.3.1.5.3. Channel Strategy 21.3.2. Corning Incorporated 21.3.2.1. Overview 21.3.2.2. Service Portfolio 21.3.2.3. Profitability by Market Segments(Service/Channel/Country) 21.3.2.4. Service Footprint 21.3.2.5. Strategy Overview 21.3.2.5.1. Marketing Strategy 21.3.2.5.2. Service Strategy 21.3.2.5.3. Channel Strategy 21.3.3. Merck KGaA 21.3.3.1. Overview 21.3.3.2. Service Portfolio 21.3.3.3. Profitability by Market Segments(Service/Channel/Country) 21.3.3.4. Service Footprint 21.3.3.5. Strategy Overview 21.3.3.5.1. Marketing Strategy 21.3.3.5.2. Service Strategy 21.3.3.5.3. Channel Strategy 21.3.4. Lonza Group Ltd 21.3.4.1. Overview 21.3.4.2. Service Portfolio 21.3.4.3. Profitability by Market Segments(Service/Channel/Country) 21.3.4.4. Service Footprint 21.3.4.5. Strategy Overview 21.3.4.5.1. Marketing Strategy 21.3.4.5.2. Service Strategy 21.3.4.5.3. Channel Strategy 21.3.5. Sartorius AG 21.3.5.1. Overview 21.3.5.2. Service Portfolio 21.3.5.3. Profitability by Market Segments(Service/Channel/Country) 21.3.5.4. Service Footprint 21.3.5.5. Strategy Overview 21.3.5.5.1. Marketing Strategy 21.3.5.5.2. Service Strategy 21.3.5.5.3. Channel Strategy 21.3.6. Tecan Trading AG 21.3.6.1. Overview 21.3.6.2. Service Portfolio 21.3.6.3. Profitability by Market Segments(Service/Channel/Country) 21.3.6.4. Service Footprint 21.3.6.5. Strategy Overview 21.3.6.5.1. Marketing Strategy 21.3.6.5.2. Service Strategy 21.3.6.5.3. Channel Strategy 21.3.7. Hamilton Medical AG 21.3.7.1. Overview 21.3.7.2. Service Portfolio 21.3.7.3. Profitability by Market Segments(Service/Channel/Country) 21.3.7.4. Service Footprint 21.3.7.5. Strategy Overview 21.3.7.5.1. Marketing Strategy 21.3.7.5.2. Service Strategy 21.3.7.5.3. Channel Strategy 21.3.8. Biospherix 21.3.8.1. Overview 21.3.8.2. Service Portfolio 21.3.8.3. Profitability by Market Segments(Service/Channel/Country) 21.3.8.4. Service Footprint 21.3.8.5. Strategy Overview 21.3.8.5.1. Marketing Strategy 21.3.8.5.2. Service Strategy 21.3.8.5.3. Channel Strategy 21.3.9. Promocell GmbH 21.3.9.1. Overview 21.3.9.2. Service Portfolio 21.3.9.3. Profitability by Market Segments(Service/Channel/Country) 21.3.9.4. Service Footprint 21.3.9.5. Strategy Overview 21.3.9.5.1. Marketing Strategy 21.3.9.5.2. Service Strategy 21.3.9.5.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Automated Cell Culture Systems Market
